1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow INCB039110: new trials by email Literature Review of INCB039110 trials Research Report on INCB039110
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease Itacitinib, Placebo, Methylprednisolone - Chronic Graft-versus-host Disease | Phase 2 / Phase 3 | Terminated | Incyte Corporation | 155 | 2019-01-17 | 2025-10-20 |
| GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease Itacitinib, Placebo, Prednisone - Graft-versus-host Disease (GVHD) | Phase 3 | Completed | Incyte Corporation | 439 | 2017-07-19 | 2025-09-02 |
Graft vs Host Disease (2) · Bronchiolitis Obliterans Syndrome (1)
Austria (2) · Belgium (2) · Finland (2) · France (2) · Germany (2) · Greece (2) · Israel (2) · Italy (2) · Poland (2) · Spain (2) · Switzerland (2) · United Kingdom (2) · United States (2) · Australia (1) · Canada (1)
2017 (1), 2018 (1)